- Marketwired•5 days agoGeoVax to Collaborate with Georgia State University on Development of Therapeutic Hepatitis B Vaccine
GeoVax Labs, Inc. , a biotechnology company developing human vaccines, announced today that it has entered into a research collaboration agreement with Georgia State University Research Foundation to advance ...
- Marketwired•13 days ago
GeoVax Labs, Inc. announced today that it has entered into a research collaboration agreement with the Burnet Institute, a leading infectious diseases research institute in Australia, for the development ...
- American City Business Journals•17 days ago
A Smyrna-based developer of vaccines against Zika, Ebola, HIV and other infectious diseases has named a new chief scientific officer. Farshad Guirakhoo was promoted to the C-suite role at GeoVax Labs Inc. from senior vice president of research and development, his title upon joining the company in 2015. "For the past year, Farshad has been a driving force behind the growth of our vaccine development pipeline, and we are pleased to expand his role at this critical time for our company," GeoVax President and CEO Robert T. McNally said in the statement.
GOVX : Summary for GEOVAX LABS INC COM STK USD0.01 - Yahoo Finance
GeoVax Labs, Inc. (GOVX)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.07 - 0.07|
|52 Week Range||0.05 - 0.14|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.81|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|